Marijuana cuts lung cancer tumor growth in half, Harvard study shows
|
|
|
|
|

Science Daily Reports : The active ingredient in marijuana cuts tumor growth in common lung cancer in half and significantly reduces the ability of the cancer to spread, say researchers at Harvard University who tested the chemical in both lab and mouse studies.
They say this is the first set of experiments to show that the compound, Delta-tetrahydrocannabinol (THC), inhibits EGF-induced growth and migration in epidermal growth factor receptor (EGFR) expressing non-small cell lung cancer cell lines. Lung cancers that over-express EGFR are usually highly aggressive and resistant to chemotherapy.
THC that targets cannabinoid receptors CB1 and CB2 is similar in function to endocannabinoids, which are cannabinoids that are naturally produced in the body and activate these receptors. The researchers suggest that THC or other designer agents that activate these receptors might be used in a targeted fashion to treat lung cancer.
Must-Watch: Marijuana Legalization Hearing in Washington State Part 1
Marijuana activists, politicians, and former and current law enforcement officials spoke to the Washington State legislature in support (and against) of Rep. Mary Lou Dickerson’s House Bill 1550, which would legalize cannabis and make it available for retail purchase in State-run liquor stores.
Must-Watch: Marijuana Legalization Hearing in Washington State Part 2
Marijuana activists, politicians, and former and current law enforcement officials spoke to the Washington State legislature in support (and against) of Rep. Mary Lou Dickerson’s House Bill 1550, which would legalize cannabis and make it available for retail purchase in State-run liquor stores.
HYPEEATER.com is your #1 source for Hip-Hop celebrity news, photos, exclusive music videos, interviews and all the latest in the world of hip hop and R&B music.















